vs

Side-by-side financial comparison of Orange County Bancorp, Inc. (OBT) and Outset Medical, Inc. (OM). Click either name above to swap in a different company.

Orange County Bancorp, Inc. is the larger business by last-quarter revenue ($33.0M vs $28.9M, roughly 1.1× Outset Medical, Inc.). Orange County Bancorp, Inc. runs the higher net margin — 37.6% vs -67.5%, a 105.1% gap on every dollar of revenue. On growth, Orange County Bancorp, Inc. posted the faster year-over-year revenue change (20.6% vs -2.0%). Orange County Bancorp, Inc. produced more free cash flow last quarter ($41.3M vs $-9.7M). Over the past eight quarters, Orange County Bancorp, Inc.'s revenue compounded faster (14.3% CAGR vs 1.2%).

Orange County Bancorp, Inc. is a Delaware-registered bank holding company operating mainly in New York, U.S. It offers a full range of retail and commercial banking services, including deposit accounts, loans and wealth management solutions, serving individual consumers, small and mid-sized corporate clients in its regional footprint.

Outset Medical, Inc. is a medical technology company focused on developing and commercializing innovative dialysis solutions for patients living with kidney disease. Its flagship Tablo Hemodialysis System supports use in acute care facilities, outpatient clinics, and home settings, serving healthcare providers and patients across the U.S. and select international markets.

OBT vs OM — Head-to-Head

Bigger by revenue
OBT
OBT
1.1× larger
OBT
$33.0M
$28.9M
OM
Growing faster (revenue YoY)
OBT
OBT
+22.6% gap
OBT
20.6%
-2.0%
OM
Higher net margin
OBT
OBT
105.1% more per $
OBT
37.6%
-67.5%
OM
More free cash flow
OBT
OBT
$51.1M more FCF
OBT
$41.3M
$-9.7M
OM
Faster 2-yr revenue CAGR
OBT
OBT
Annualised
OBT
14.3%
1.2%
OM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OBT
OBT
OM
OM
Revenue
$33.0M
$28.9M
Net Profit
$12.4M
$-19.5M
Gross Margin
42.4%
Operating Margin
41.4%
-61.1%
Net Margin
37.6%
-67.5%
Revenue YoY
20.6%
-2.0%
Net Profit YoY
73.5%
24.0%
EPS (diluted)
$0.94
$0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OBT
OBT
OM
OM
Q4 25
$33.0M
$28.9M
Q3 25
$33.7M
$29.4M
Q2 25
$32.5M
$31.4M
Q1 25
$28.0M
$29.8M
Q4 24
$27.4M
$29.5M
Q3 24
$27.1M
$28.7M
Q2 24
$27.9M
$27.4M
Q1 24
$25.3M
$28.2M
Net Profit
OBT
OBT
OM
OM
Q4 25
$12.4M
$-19.5M
Q3 25
$10.0M
$-17.8M
Q2 25
$10.5M
$-18.5M
Q1 25
$8.7M
$-25.8M
Q4 24
$7.2M
$-25.6M
Q3 24
$3.2M
$-27.9M
Q2 24
$8.2M
$-34.5M
Q1 24
$9.3M
$-39.9M
Gross Margin
OBT
OBT
OM
OM
Q4 25
42.4%
Q3 25
39.4%
Q2 25
37.8%
Q1 25
37.2%
Q4 24
36.5%
Q3 24
34.3%
Q2 24
35.7%
Q1 24
29.2%
Operating Margin
OBT
OBT
OM
OM
Q4 25
41.4%
-61.1%
Q3 25
38.6%
-53.7%
Q2 25
41.9%
-53.7%
Q1 25
40.3%
-55.1%
Q4 24
32.8%
-74.2%
Q3 24
14.8%
-83.2%
Q2 24
36.6%
-112.3%
Q1 24
45.9%
-131.0%
Net Margin
OBT
OBT
OM
OM
Q4 25
37.6%
-67.5%
Q3 25
29.7%
-60.6%
Q2 25
32.2%
-59.0%
Q1 25
31.1%
-86.7%
Q4 24
26.2%
-87.0%
Q3 24
11.8%
-97.5%
Q2 24
29.4%
-125.8%
Q1 24
36.7%
-141.8%
EPS (diluted)
OBT
OBT
OM
OM
Q4 25
$0.94
$0.33
Q3 25
$0.75
$-1.00
Q2 25
$0.87
$-1.04
Q1 25
$0.77
$-3.66
Q4 24
$0.64
$-7.21
Q3 24
$0.28
$-8.02
Q2 24
$0.73
$-9.96
Q1 24
$0.82
$-11.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OBT
OBT
OM
OM
Cash + ST InvestmentsLiquidity on hand
$168.9M
Total DebtLower is stronger
$96.2M
Stockholders' EquityBook value
$284.4M
$127.0M
Total Assets
$2.7B
$264.5M
Debt / EquityLower = less leverage
0.76×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OBT
OBT
OM
OM
Q4 25
$168.9M
Q3 25
$178.6M
Q2 25
$184.1M
Q1 25
$189.0M
Q4 24
$158.7M
Q3 24
$175.6M
Q2 24
$194.8M
Q1 24
$226.9M
Total Debt
OBT
OBT
OM
OM
Q4 25
$96.2M
Q3 25
Q2 25
Q1 25
Q4 24
$197.4M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
OBT
OBT
OM
OM
Q4 25
$284.4M
$127.0M
Q3 25
$270.1M
$142.4M
Q2 25
$252.6M
$154.8M
Q1 25
$201.3M
$169.9M
Q4 24
$185.5M
$26.8M
Q3 24
$193.1M
$47.8M
Q2 24
$177.5M
$68.6M
Q1 24
$168.7M
$93.2M
Total Assets
OBT
OBT
OM
OM
Q4 25
$2.7B
$264.5M
Q3 25
$2.6B
$277.3M
Q2 25
$2.6B
$288.8M
Q1 25
$2.6B
$301.2M
Q4 24
$2.5B
$275.8M
Q3 24
$2.5B
$292.9M
Q2 24
$2.5B
$314.5M
Q1 24
$2.5B
$346.2M
Debt / Equity
OBT
OBT
OM
OM
Q4 25
0.76×
Q3 25
Q2 25
Q1 25
Q4 24
7.36×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OBT
OBT
OM
OM
Operating Cash FlowLast quarter
$43.8M
$-9.5M
Free Cash FlowOCF − Capex
$41.3M
$-9.7M
FCF MarginFCF / Revenue
125.1%
-33.7%
Capex IntensityCapex / Revenue
7.6%
0.8%
Cash ConversionOCF / Net Profit
3.53×
TTM Free Cash FlowTrailing 4 quarters
$69.6M
$-47.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OBT
OBT
OM
OM
Q4 25
$43.8M
$-9.5M
Q3 25
$30.2M
$-6.3M
Q2 25
$-5.0M
$-4.8M
Q1 25
$4.8M
$-25.7M
Q4 24
$34.6M
$-16.5M
Q3 24
$10.2M
$-20.6M
Q2 24
$9.3M
$-33.3M
Q1 24
$2.3M
$-45.9M
Free Cash Flow
OBT
OBT
OM
OM
Q4 25
$41.3M
$-9.7M
Q3 25
$29.6M
$-6.5M
Q2 25
$-5.7M
$-5.1M
Q1 25
$4.3M
$-25.8M
Q4 24
$32.9M
$-16.5M
Q3 24
$10.0M
$-21.0M
Q2 24
$9.2M
$-33.5M
Q1 24
$2.0M
$-46.3M
FCF Margin
OBT
OBT
OM
OM
Q4 25
125.1%
-33.7%
Q3 25
87.8%
-22.0%
Q2 25
-17.5%
-16.3%
Q1 25
15.5%
-86.7%
Q4 24
120.0%
-56.1%
Q3 24
36.7%
-73.1%
Q2 24
32.8%
-122.2%
Q1 24
7.9%
-164.3%
Capex Intensity
OBT
OBT
OM
OM
Q4 25
7.6%
0.8%
Q3 25
1.8%
0.5%
Q2 25
2.3%
0.9%
Q1 25
1.8%
0.4%
Q4 24
6.3%
0.1%
Q3 24
1.1%
1.4%
Q2 24
0.4%
0.4%
Q1 24
1.0%
1.3%
Cash Conversion
OBT
OBT
OM
OM
Q4 25
3.53×
Q3 25
3.01×
Q2 25
-0.47×
Q1 25
0.56×
Q4 24
4.83×
Q3 24
3.19×
Q2 24
1.13×
Q1 24
0.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OBT
OBT

Segment breakdown not available.

OM
OM

Consumables Product$13.5M47%
Service And Other Revenue$9.0M31%
Consoles Product$6.4M22%

Related Comparisons